SkinBioTherapeutics plc has appointed an interim CEO for the next six months as its former leader is investigated over concerns that he misrepresented results. Rachel Parsonage, who currently runs her own advisory consultancy, has agreed to take the role on a temporary basis after former CEO Stuart Ashman resigned recently. Alyson Levett, who only joined … Continue reading SkinBioTherapeutics shares bounce back on CEO announcement